Palliative in-patient cancer treatment in an anthroposophic hospital: II. Quality of life during and after stationary treatment, and subjective treatment benefits

被引:20
作者
Heusser, Peter
Braun, Sarah Berger
Bertschy, Manuel
Burkhard, Rene
Ziegler, Renatus
Helwig, Silke
van Wegberg, Brigitte
Cerny, Thomas
机构
[1] Univ Bern, Inst Complementary Med KIKOM, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Stat Math, CH-3012 Bern, Switzerland
[3] Inst Hiscia, Arlesheim, Switzerland
[4] Lukas Klin, Arlesheim, Switzerland
[5] Klin Hirslanden, Zurich, Switzerland
[6] Kantonsspital, Dept Internal Med, CH-9007 St Gallen, Switzerland
来源
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE | 2006年 / 13卷 / 03期
关键词
cancer treatment; palliative; anthroposophic medicine; CAM; quality of life;
D O I
10.1159/000092448
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: There is an increasing demand for comprehensive forms of palliative cancer care, meeting physical as well as emotional, cognitive, spiritual and social needs. Therapy programs of anthroposophic hospitals are aimed at improving health and quality of life (QoL) at these levels. However, data on the influence of these programs on QoL of patients with advanced cancer are scarce. Patients and Methods: 144 in-patients with advanced epithelial cancers were treated at the anthroposophic Lukas Klinik, Arlesheim, Switzerland. QoL was assessed upon admission, discharge and after 4 months, using 20 functional scales from the questionnaires EORTC QLQ-C30, HADS and SELT-M. Statistical testing was performed with the Wilcoxon signed rank test. At month 4, subjectively perceived benefits from anthroposophic medicine ( AM) and conventional cancer therapy (CCT) were assessed by telephone. Objective: The aim was to provide an account of global, physical, emotional, cognitive-spiritual and social QoL developments in advanced cancer patients, during and after in-patient AM treatment, and to investigate subjective benefits from AM and CCT. Results: QoL improvements were observed in all 20 dimensions (12 significant). Compared to related studies, improvements were fairly high. At month 4, QoL scores had decreased but were still above baseline in all 20 dimensions. Both AM and CCT were perceived as beneficial. Conclusion: Our data provide evidence that in-patient therapy at an anthroposophic hospital can lead to significant QoL improvements, especially in emotional, but also global, physical, cognitive-spiritual and social aspects. Benefits of AM were experienced on the physical, emotional, cognitive-spiritual and social level. Benefits of CCT were tumor-focused.
引用
收藏
页码:156 / 166
页数:11
相关论文
共 75 条
[31]  
Heiny B., 1991, Krebsmed, V12, P1
[32]   Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial [J].
Helsing, M ;
Bergman, B ;
Thaning, L ;
Hero, U .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (07) :1036-1044
[33]  
HEUSSER P, 1991, J ANTHROPOSOPHIC MED, V8, P5
[34]   Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine [J].
Heusser, Peter ;
Braun, Sarah Berger ;
Ziegler, Renatus ;
Bertschy, Manuel ;
Helwig, Silke ;
van Wegberg, Brigitte ;
Cerny, Thomas .
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE, 2006, 13 (02) :94-100
[35]  
Heywood K, 2003, Complement Ther Nurs Midwifery, V9, P125, DOI 10.1016/S1353-6117(03)00021-0
[36]  
HILLER B, 2003, DTSCH ARZTEBL, V100, pA1182
[37]   The effects of music therapy on the quality and length of life of people diagnosed with terminal cancer [J].
Hilliard, RE .
JOURNAL OF MUSIC THERAPY, 2003, 40 (02) :113-137
[38]   Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care? [J].
Holtom, N ;
Barraclough, J .
PALLIATIVE MEDICINE, 2000, 14 (03) :219-220
[39]  
HURNY C, 1994, SCHWEIZ MED WSCHR, V124, P55
[40]   Quality of life in palliative cancer care: Results from a cluster randomized trial [J].
Jordhoy, MS ;
Fayers, P ;
Loge, JH ;
Ahlner-Elmqvist, M ;
Kaasa, S .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3884-3894